Speaker illustration

Doctor Eva Blychert

AstraZeneca Pharmaceutical Technology & Development, Gothenburg (Sweden)

Pharmacokinetic profiles of orodispersible ticagrelor tablets in healthy Western and Japanese subjects.

Event: ESC CONGRESS 2017

Topic: Thrombosis and platelets

Session: Acute coronary syndromes

Thumbnail

This platform is supported by

logo Novo Nordisk